OVERVIEW
OVERVIEW
OVERVIEW
OVERVIEW
NEXVOX is a revolutionary neuro-immersive technology that integrates real-time neuro-feedback, cognitive sound mapping, and AI analytics. By encouraging neuroplasticity, and harnessing the therapeutic power of music, NEXVOX creates an exponential feedback loop for unrivaled mental and physical well-being.
NEXVOX is a revolutionary neuro-immersive technology that integrates real-time neuro-feedback, cognitive sound mapping, and AI analytics. By encouraging neuroplasticity, and harnessing the therapeutic power of music, NEXVOX creates an exponential feedback loop for unrivaled mental and physical well-being.
NEXVOX is a revolutionary neuro-immersive technology that integrates real-time neuro-feedback, cognitive sound mapping, and AI analytics. By encouraging neuroplasticity, and harnessing the therapeutic power of music, NEXVOX creates an exponential feedback loop for unrivaled mental and physical well-being.
NEXVOX is a revolutionary neuro-immersive technology that integrates real-time neuro-feedback, cognitive sound mapping, and AI analytics. By encouraging neuroplasticity, and harnessing the therapeutic power of music, NEXVOX creates an exponential feedback loop for unrivaled mental and physical well-being.
EXECUTIVE TEAM
EXECUTIVE TEAM
EXECUTIVE TEAM
EXECUTIVE TEAM
JON-PAUL COX
NEXVOX CEO
Business growth visionary. Market expansion strategist.
Strategic partnerships powerhouse. Proven leader in scaling early-stage ventures and driving revenue.
JON-PAUL COX
NEXVOX CEO
Business growth visionary. Market expansion strategist.
Strategic partnerships powerhouse. Proven leader in scaling early-stage ventures and driving revenue.
JON-PAUL COX
NEXVOX CEO
Business growth visionary. Market expansion strategist.
Strategic partnerships powerhouse. Proven leader in scaling early-stage ventures and driving revenue.
JON-PAUL COX
NEXVOX CEO
Business growth visionary. Market expansion strategist.
Strategic partnerships powerhouse. Proven leader in scaling early-stage ventures and driving revenue.
MASHA BRODSKAYA
CO-FOUNDER, CVO
Virtual Reality & Neuroscience-music pioneer. Creative technologist.
Grammy-award artist, producer, composer. Innovator and educator.
MASHA BRODSKAYA
CO-FOUNDER, CVO
Virtual Reality & Neuroscience-music pioneer. Creative technologist.
Grammy-award artist, producer, composer. Innovator and educator.
MASHA BRODSKAYA
CO-FOUNDER, CVO
Virtual Reality & Neuroscience-music pioneer. Creative technologist.
Grammy-award artist, producer, composer. Innovator and educator.
MASHA BRODSKAYA
CO-FOUNDER, CVO
Virtual Reality & Neuroscience-music pioneer. Creative technologist.
Grammy-award artist, producer, composer. Innovator and educator.
BRIAN FORBES
CO-FOUNDER, CTO
Grammy-winning producer. Tech innovator, energy technologist.
The leading expert in neurofeedback and immersive technology.
MICHAL ARAD, PhD
CHIEF SCIENCE OFFICER
Behavioral neuroscience expert. 20 years of academic research.
Transforms scientific discoveries into cutting-edge technologies.
MICHAL ARAD, PhD
CHIEF SCIENCE OFFICER
Behavioral neuroscience expert. 20 years of academic research.
Transforms scientific discoveries into cutting-edge technologies.
MICHAL ARAD, PhD
CHIEF SCIENCE OFFICER
Behavioral neuroscience expert. 20 years of academic research.
Transforms scientific discoveries into cutting-edge technologies.
MICHAL ARAD, PhD
CHIEF SCIENCE OFFICER
Behavioral neuroscience expert. 20 years of academic research.
Transforms scientific discoveries into cutting-edge technologies.
SHANNON HOPPENSTEDT
LEAD THERAPIST
Counseling psychology specialist. Trauma-healing expert.
Integrates EMDR, energy healing, and ketamine-assisted psychotherapy.
SHANNON HOPPENSTEDT
LEAD THERAPIST
Counseling psychology specialist. Trauma-healing expert.
Integrates EMDR, energy healing, and ketamine-assisted psychotherapy.
SHANNON HOPPENSTEDT
LEAD THERAPIST
Counseling psychology specialist. Trauma-healing expert.
Integrates EMDR, energy healing, and ketamine-assisted psychotherapy.
SHANNON HOPPENSTEDT
LEAD THERAPIST
Counseling psychology specialist. Trauma-healing expert.
Integrates EMDR, energy healing, and ketamine-assisted psychotherapy.
PROBLEM
PROBLEM
PROBLEM
PROBLEM
We are facing an urgent global mental health crisis, and current treatments like SSRIs are failing.
We are facing an urgent global mental health crisis, and current treatments like SSRIs are failing.
We are facing an urgent global mental health crisis, and current treatments like SSRIs are failing.
We are facing an urgent global mental health crisis, and current treatments like SSRIs are failing.
1 in 4 people will experience mental health disorders in their lifetime, and 42% of adults in the U.S. have sought therapy or counseling.
1 in 4 people will experience mental health disorders in their lifetime, and 42% of adults in the U.S. have sought therapy or counseling.
1 in 4 people will experience mental health disorders in their lifetime, and 42% of adults in the U.S. have sought therapy or counseling.
1 in 4 people will experience mental health disorders in their lifetime, and 42% of adults in the U.S. have sought therapy or counseling.
Our current systems perpetuate the cycle of disease, allowing poor mental health to spiral into broader challenges. The mental health market is in dire need of innovation.
Our current systems perpetuate the cycle of disease, allowing poor mental health to spiral into broader challenges. The mental health market is in dire need of innovation.
Our current systems perpetuate the cycle of disease, allowing poor mental health to spiral into broader challenges. The mental health market is in dire need of innovation.
Our current systems perpetuate the cycle of disease, allowing poor mental health to spiral into broader challenges. The mental health market is in dire need of innovation.
SOLUTION
SOLUTION
SOLUTION
SOLUTION
NEXVOX is merging cutting-edge neurotechnology with cognitive sound mapping and AI to offer the ultimate personalized and non-invasive solution for mental health.
NEXVOX is merging cutting-edge neurotechnology with cognitive sound mapping and AI to offer the ultimate personalized and non-invasive solution for mental health.
NEXVOX is merging cutting-edge neurotechnology with cognitive sound mapping and AI to offer the ultimate personalized and non-invasive solution for mental health.
NEXVOX is merging cutting-edge neurotechnology with cognitive sound mapping and AI to offer the ultimate personalized and non-invasive solution for mental health.
BENEFITS
BENEFITS
BENEFITS
BENEFITS
Significant reduction of Anxiety and Depression.
Mood Elevation.
Sleep Improvement.
Enhanced Focus and Concentration.
Augmented Self-Awareness and Body-Mind connection
Significant reduction of Anxiety and Depression.
Mood Elevation.
Sleep Improvement.
Enhanced Focus and Concentration.
Augmented Self-Awareness and Body-Mind connection
Significant reduction of Anxiety and Depression.
Mood Elevation.
Sleep Improvement.
Enhanced Focus and Concentration.
Augmented Self-Awareness and Body-Mind connection
Significant reduction of Anxiety and Depression.
Mood Elevation.
Sleep Improvement.
Enhanced Focus and Concentration.
Augmented Self-Awareness and Body-Mind connection
PRODUCT
TRACTION
PRODUCT
TRACTION
PRODUCT
TRACTION
PRODUCT
TRACTION
From Lab to Life: Proven Results
Pre-Clinical Proof: Single-Session Efficacy
From Lab to Life: Proven Results
Pre-Clinical Proof: Single-Session Efficacy
From Lab to Life: Proven Results
Pre-Clinical Proof: Single-Session Efficacy
From Lab to Life: Proven Results
Pre-Clinical Proof: Single-Session Efficacy
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
In addition, our therapeutic trials have shown significant improvements in mental well-being, reduction in depression and anxiety levels, and improvement in sleep and overall mood.
In addition, our therapeutic trials have shown significant improvements in mental well-being, reduction in depression and anxiety levels, and improvement in sleep and overall mood.
In addition, our therapeutic trials have shown significant improvements in mental well-being, reduction in depression and anxiety levels, and improvement in sleep and overall mood.
In addition, our therapeutic trials have shown significant improvements in mental well-being, reduction in depression and anxiety levels, and improvement in sleep and overall mood.
COMMERCIAL
TRACTION
COMMERCIAL
TRACTION
COMMERCIAL
TRACTION
COMMERCIAL
TRACTION
8 therapists in beta program (30+ therapists in onboarding)
1,200+ pilot sessions logged
3 distribution partnerships under MOU
8 therapists in beta program (30+ therapists in onboarding)
1,200+ pilot sessions logged
3 distribution partnerships under MOU
8 therapists in beta program (30+ therapists in onboarding)
1,200+ pilot sessions logged
3 distribution partnerships under MOU
8 therapists in beta program (30+ therapists in onboarding)
1,200+ pilot sessions logged
3 distribution partnerships under MOU
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
40-person pilot study shows immediate, measurable wellness improvements
87-90% of participants experienced significant stress relief and mood enhancement
Sleep quality and mental clarity improved for vast majority of users
94% satisfaction rate demonstrates strong product-market fit potential
CLINICAL
STUDIES
CLINICAL
STUDIES
CLINICAL
STUDIES
CLINICAL
STUDIES
Tel-Hai College study: 40 children with PTSD (ongoing)
Niv Nirel Center: Combat trauma program with 20 therapists/second responders (launching)
Tel-Hai College study: 40 children with PTSD (ongoing)
Niv Nirel Center: Combat trauma program with 20 therapists/second responders (launching)
Tel-Hai College study: 40 children with PTSD (ongoing)
Niv Nirel Center: Combat trauma program with 20 therapists/second responders (launching)
Tel-Hai College study: 40 children with PTSD (ongoing)
Niv Nirel Center: Combat trauma program with 20 therapists/second responders (launching)
BUSINESS
MODEL
BUSINESS
MODEL
BUSINESS
MODEL
BUSINESS
MODEL
NEXVOX targets the global community of
NEXVOX targets the global community of
NEXVOX targets the global community of
NEXVOX targets the global community of
300+ million people suffering from anxiety or depression disorders.
300+ million people suffering from anxiety or depression disorders.
300+ million people suffering from anxiety or depression disorders.
300+ million people suffering from anxiety or depression disorders.
Our initial revenue strategy is anchored in direct partnerships with therapists, launched in early 2025 with an exclusive release of the NEXVOX system for clinical use in early 2026. We have already delivered transformative results through private and group sessions, immersive retreats, and collaborations with leading therapists, building a strong foundation of trust and proven efficacy.
This therapist-first approach establishes an evidence-based foothold in the mental health space. Building on our successful retreats and clinical collaborations, we will expand access through branded clinics and broader market offerings by early 2026.
Our initial revenue strategy is anchored in direct partnerships with therapists, launched in early 2025 with an exclusive release of the NEXVOX system for clinical use in early 2026. We have already delivered transformative results through private and group sessions, immersive retreats, and collaborations with leading therapists, building a strong foundation of trust and proven efficacy.
This therapist-first approach establishes an evidence-based foothold in the mental health space. Building on our successful retreats and clinical collaborations, we will expand access through branded clinics and broader market offerings by early 2026.
Our initial revenue strategy is anchored in direct partnerships with therapists, launched in early 2025 with an exclusive release of the NEXVOX system for clinical use in early 2026. We have already delivered transformative results through private and group sessions, immersive retreats, and collaborations with leading therapists, building a strong foundation of trust and proven efficacy.
This therapist-first approach establishes an evidence-based foothold in the mental health space. Building on our successful retreats and clinical collaborations, we will expand access through branded clinics and broader market offerings by early 2026.
Our initial revenue strategy is anchored in direct partnerships with therapists, launched in early 2025 with an exclusive release of the NEXVOX system for clinical use in early 2026. We have already delivered transformative results through private and group sessions, immersive retreats, and collaborations with leading therapists, building a strong foundation of trust and proven efficacy.
This therapist-first approach establishes an evidence-based foothold in the mental health space. Building on our successful retreats and clinical collaborations, we will expand access through branded clinics and broader market offerings by early 2026.
MARKET
OPPORTUNITY
MARKET
OPPORTUNITY
MARKET
OPPORTUNITY
MARKET
OPPORTUNITY
The global tech-enabled mental health market is valued at
The global tech-enabled mental health market is valued at
The global tech-enabled mental health market is valued at
The global tech-enabled mental health market is valued at
$75B
with the brain training & cognitive wellness market projected to reach
with the brain training & cognitive wellness market projected to reach
with the brain training & cognitive wellness market projected to reach
with the brain training & cognitive wellness market projected to reach
$85B
by 2032
by 2032
by 2032
by 2032
Therapist technology adoption is estimated at 30–40%, with an average potential of $12K annual B2B revenue per professional. Healthcare adoption follows a curve of 2–5% in early stages and 35–55% in maturity. Consumer EEG device adoption is projected at 10%, with the consumer wellness market growing at a 20.7% CAGR through 2032.
Therapist technology adoption is estimated at 30–40%, with an average potential of $12K annual B2B revenue per professional. Healthcare adoption follows a curve of 2–5% in early stages and 35–55% in maturity. Consumer EEG device adoption is projected at 10%, with the consumer wellness market growing at a 20.7% CAGR through 2032.
Therapist technology adoption is estimated at 30–40%, with an average potential of $12K annual B2B revenue per professional. Healthcare adoption follows a curve of 2–5% in early stages and 35–55% in maturity. Consumer EEG device adoption is projected at 10%, with the consumer wellness market growing at a 20.7% CAGR through 2032.
Therapist technology adoption is estimated at 30–40%, with an average potential of $12K annual B2B revenue per professional. Healthcare adoption follows a curve of 2–5% in early stages and 35–55% in maturity. Consumer EEG device adoption is projected at 10%, with the consumer wellness market growing at a 20.7% CAGR through 2032.
TAM
Global tech-enabled mental health market –
Global tech-enabled mental health market –
Global tech-enabled mental health market –
Global tech-enabled mental health market –
$75B
Brain training & cognitive wellness
market by 2032 –
Brain training & cognitive wellness
market by 2032 –
Brain training & cognitive wellness
market by 2032 –
Brain training & cognitive wellness
market by 2032 –
$85B
SAM
240K technology-adopting professionals
@ $15K avg spend –
240K technology-adopting professionals
@ $15K avg spend –
240K technology-adopting professionals
@ $15K avg spend –
240K technology-adopting professionals
@ $15K avg spend –
$3.6B
Consumer wellness technology
focused on brain health –
Consumer wellness technology
focused on brain health –
Consumer wellness technology
focused on brain health –
Consumer wellness technology
focused on brain health –
$25B
SOM
15K early adopters by Year 3 @ $12K ARPU –
15K early adopters by Year 3 @ $12K ARPU –
15K early adopters by Year 3 @ $12K ARPU –
15K early adopters by Year 3 @ $12K ARPU –
$180M
2M active users by Year 5 @ $250 ARPU –
2M active users by Year 5 @ $250 ARPU –
2M active users by Year 5 @ $250 ARPU –
2M active users by Year 5 @ $250 ARPU –
$500M
COMPETITIVE
POSITIONING
COMPETITIVE
POSITIONING
COMPETITIVE
POSITIONING
COMPETITIVE
POSITIONING
We occupy a unique position in the market with a deep neuroscience base, adaptive machine learning, personalized delivery, and multiple platform delivery options, including VR/AR for the metaverse. We have multiple revenue streams and potential crossover to non-drug-based therapeutics.
We occupy a unique position in the market with a deep neuroscience base, adaptive machine learning, personalized delivery, and multiple platform delivery options, including VR/AR for the metaverse. We have multiple revenue streams and potential crossover to non-drug-based therapeutics.
We occupy a unique position in the market with a deep neuroscience base, adaptive machine learning, personalized delivery, and multiple platform delivery options, including VR/AR for the metaverse. We have multiple revenue streams and potential crossover to non-drug-based therapeutics.
We occupy a unique position in the market with a deep neuroscience base, adaptive machine learning, personalized delivery, and multiple platform delivery options, including VR/AR for the metaverse. We have multiple revenue streams and potential crossover to non-drug-based therapeutics.
FUNDING
FUNDING
FUNDING
FUNDING
NEXVOX seeks to raise
NEXVOX seeks to raise
NEXVOX seeks to raise
NEXVOX seeks to raise
$2M
$2M
$2M
at a
at a
at a
at a
$8M
$8M
$8M
$8M
pre-money valuation. Funds will be used for:
pre-money valuation. Funds will be used for:
pre-money valuation. Funds will be used for:
pre-money valuation. Funds will be used for:
• Product Dev & Tech – $750K
• Product Dev & Tech –
$750K
• Product Dev & Tech – $750K
• Go-to-Market & Sales – $750K
• Go-to-Market & Sales –
$750K
• Go-to-Market & Sales – $750K
• Operations – $600K
• Operations –
$600K
• Operations – $600K
• Clinical trial – $900K
• Clinical trial –
$900K
• Clinical trial – $900K
THOUGHT
LEADERS
ON NEXVOX
THOUGHT
LEADERS
ON NEXVOX
THOUGHT
LEADERS
ON NEXVOX
Nouriel Roubini
Nouriel Roubini
Nouriel Roubini
A WORLD-FAMOUS ECONOMIST,
PHILANTHROPIST, NEXVOX EVANGELIST
A WORLD-FAMOUS ECONOMIST,
PHILANTHROPIST, NEXVOX EVANGELIST
A WORLD-FAMOUS ECONOMIST,
PHILANTHROPIST, NEXVOX EVANGELIST
“I believe NEXVOX is a true revolution in the field of brain-health and
mindfulness. It helps you restore a healthy body-mind connection, while also creating a
unique imprint of your mind and soul.”
“I believe NEXVOX is a true revolution in the field of brain-health and
mindfulness. It helps you restore a healthy body-mind connection, while also creating a
unique imprint of your mind and soul.”
“I believe NEXVOX is a true revolution in the field of brain-health and
mindfulness. It helps you restore a healthy body-mind connection, while also creating a
unique imprint of your mind and soul.”
Mike Pell
Mike Pell
Mike Pell
DIRECTOR AT MICROSOFT
GARAGE
DIRECTOR AT MICROSOFT
GARAGE
DIRECTOR AT MICROSOFT
GARAGE
“The opportunity this breakthrough approach creates is truly game-changing. NEXVOX
is a leap into the future of our being. It democratizes access to mental health, while
experiencing the creation of personal masterpieces.”
“The opportunity this breakthrough approach creates is truly game-changing. NEXVOX
is a leap into the future of our being. It democratizes access to mental health, while
experiencing the creation of personal masterpieces.”
“The opportunity this breakthrough approach creates is truly game-changing. NEXVOX
is a leap into the future of our being. It democratizes access to mental health, while
experiencing the creation of personal masterpieces.”
Bessel van der Kolk
Bessel van der Kolk
Bessel van der Kolk
PSYCHIATRIST, WORLD-RENOWNED
TRAUMA & NEUROSCIENCE
SPECIALIST
PSYCHIATRIST, WORLD-RENOWNED
TRAUMA & NEUROSCIENCE
SPECIALIST
PSYCHIATRIST, WORLD-RENOWNED
TRAUMA & NEUROSCIENCE
SPECIALIST
"NEXVOX is a great tool. I can clearly see how it helps put you in a mindful state and can also be highly effective for improving sleep.”
"NEXVOX is a great tool. I can clearly see how it helps put you in a mindful state and can also be highly effective for improving sleep.”
"NEXVOX is a great tool. I can clearly see how it helps put you in a mindful state and can also be highly effective for improving sleep.”
